Consistently, in our previous study on BC, we found that the frequency of protumorgenic subtypes of CD8+ T cells producing IL-4 and IL-17, remarkably increased in the tumor-draining lymph nodes along with tumor progression [24]. This evidence concerns the gene IL17A and breast cancer.